Soft Tissue Sarcoma Market on Track for Major Expansion by 2032, According to DelveInsight ...
The Soft Tissue Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the ...
The Pharma Letter5 天
Three novel medicines recommended for approval by EMA/CHMP
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its ...
TipRanks on MSN5 天
Pharma Mar SA Reports Strong 2024 Financial Results
SA ( ($PHMMF) ) has released its Q4 earnings. Here is a breakdown of the information Pharma Mar SA presented to its investors. Pharma ...
pharmaphorum6 天
Boehringer bags CHMP backing for Ofev in rare lung disease
The CHMP also said it had started looking into its accelerated approval of PharmaMar’s Yondelis (trabectedin) for relapsed ovarian cancer, after a clinical trial was stopped prematurely because ...